Donald C. Porter

1.3k total citations
20 papers, 853 citations indexed

About

Donald C. Porter is a scholar working on Molecular Biology, Oncology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Donald C. Porter has authored 20 papers receiving a total of 853 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 11 papers in Oncology and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in Donald C. Porter's work include Cancer-related Molecular Pathways (10 papers), Advanced Breast Cancer Therapies (3 papers) and Neurobiology and Insect Physiology Research (3 papers). Donald C. Porter is often cited by papers focused on Cancer-related Molecular Pathways (10 papers), Advanced Breast Cancer Therapies (3 papers) and Neurobiology and Insect Physiology Research (3 papers). Donald C. Porter collaborates with scholars based in United States, Greece and Italy. Donald C. Porter's co-authors include Khandan Keyomarsi, Xiaomei Chen, Michael Lowe, Thaddeus W Herliczek, Christopher G. Danes, Victor D. Vacquier, Ning Zhang, Shamsa Faruki, Gary W. Moy and Igor B. Roninson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Donald C. Porter

20 papers receiving 843 citations

Peers

Donald C. Porter

ONCOL

PRM

Susan C. Evans United States

Yan Cai China

Christoph Geisen Germany

Nobuhiro Haruki Japan

Ashley Martin United Kingdom

Honor J. Hugo Australia

R. Gätje Germany

Frédéric Bienvenu France

Edwardine Nodzenski United States

Lisa Ley United States

Susan C. Evans United States

Donald C. Porter

739 ×1.5

265 ×0.7

ONCOL

117 ×0.5

128 ×0.8

88 ×0.6

PRM

Citations per year, relative to Donald C. Porter Donald C. Porter (= 1×) peers Susan C. Evans

Countries citing papers authored by Donald C. Porter

Since Specialization

Citations

This map shows the geographic impact of Donald C. Porter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donald C. Porter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donald C. Porter more than expected).

Fields of papers citing papers by Donald C. Porter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donald C. Porter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donald C. Porter. The network helps show where Donald C. Porter may publish in the future.

Co-authorship network of co-authors of Donald C. Porter

This figure shows the co-authorship network connecting the top 25 collaborators of Donald C. Porter. A scholar is included among the top collaborators of Donald C. Porter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donald C. Porter. Donald C. Porter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Li, Chen Cheng, Jing Li, et al.. (2022). A Selective and Orally Bioavailable Quinoline-6-Carbonitrile-Based Inhibitor of CDK8/19 Mediator Kinase with Tumor-Enriched Pharmacokinetics. Journal of Medicinal Chemistry. 65(4). 3420–3433. 18 indexed citations

Li, Jing, Hao Ji, Donald C. Porter, et al.. (2019). Characterizing CDK8/19 Inhibitors through a NFκB-Dependent Cell-Based Assay. Cells. 8(10). 1208–1208. 9 indexed citations

Chen, Mengqian, Jiaxin Liang, Hao Ji, et al.. (2017). CDK8/19 Mediator kinases potentiate induction of transcription by NFκB. Proceedings of the National Academy of Sciences. 114(38). 10208–10213. 89 indexed citations

Porter, Donald C., Mengqian Chen, Jiaxin Liang, et al.. (2015). Abstract PR08: Targeting tumor microenvironment with selective small-molecule inhibitors of CDK8/19. Cancer Research. 75(1_Supplement). PR08–PR08. 1 indexed citations

Porter, Donald C., Jiaxin Liang, Vimala Kaza, et al.. (2014). Abstract 4879: Targeting the seed and the soil of cancers with selective small-molecule inhibitors of CDK8/19: Chemopotentiating, chemopreventive, anti-invasive and anti-metastatic activities. Cancer Research. 74(19_Supplement). 4879–4879. 1 indexed citations

Porter, Donald C., Christopher G. Danes, Bey-Dih Chang, et al.. (2012). Abstract 1820: CDK3: A novel tumor-selective drug target involved in AP1 activation and transcriptional damage response. Cancer Research. 72(8_Supplement). 1820–1820. 1 indexed citations

Altilia, Serena, Aurelia Santoro, Davide Malagoli, et al.. (2012). TP53 codon 72 polymorphism affects accumulation of mtDNA damage in human cells. Aging. 4(1). 28–39. 23 indexed citations

Mull, Benjamin B., et al.. (2004). Activation of Cyclin-dependent Kinase 2 by Full Length and Low Molecular Weight Forms of Cyclin E in Breast Cancer Cells. Journal of Biological Chemistry. 279(13). 12695–12705. 27 indexed citations

West, Deborah K., Donald C. Porter, Ruth L. Saxl, & Frank Maley. (2004). A Trojan Horse Approach for Silencing Thymidylate Synthase. Biochemistry. 43(28). 9177–9184. 5 indexed citations

10.

Porter, Donald C., et al.. (2001). Tumor-Specific Proteolytic Processing of Cyclin E Generates Hyperactive Lower-Molecular-Weight Forms. Molecular and Cellular Biology. 21(18). 6254–6269. 156 indexed citations

11.

Porter, Donald C.. (2000). Novel splice variants of cyclin E with altered substrate specificity. Nucleic Acids Research. 28(23). 101e–101. 44 indexed citations

12.

Porter, Donald C., et al.. (2000). Processing of cyclin E differs between normal and tumor breast cells.. PubMed. 60(2). 481–9. 85 indexed citations

13.

Porter, Donald C., et al.. (1999). Lovastatin-mediated G ₁ arrest is through inhibition of the proteasome, independent of hydroxymethyl glutaryl-CoA reductase. Proceedings of the National Academy of Sciences. 96(14). 7797–7802. 303 indexed citations

14.

Porter, Donald C., Gary W. Moy, & Victor D. Vacquier. (1989). The amino terminal sequence of sea urchin sperm histone H1 and its phosphorylation by egg cytosol. Comparative Biochemistry and Physiology Part B Comparative Biochemistry. 92(2). 381–384. 5 indexed citations

15.

Porter, Donald C., et al.. (1989). Egg jelly induces the phosphorylation of histone H3 in spermatozoa of the sea urchin Arbacia punctulata. Developmental Biology. 133(1). 111–118. 11 indexed citations

16.

Porter, Donald C., et al.. (1988). Extraction of phosphorylated sperm specific histone H1 from sea urchin eggs: Analysis of phosphopeptide maps. Biochemical and Biophysical Research Communications. 151(3). 1200–1204. 7 indexed citations

17.

Vacquier, Victor D., et al.. (1988). Monoclonal antibodies to a membrane glycoprotein induce the phosphorylation of histone H1 in sea urchin spermatozoa.. The Journal of Cell Biology. 107(6). 2021–2027. 11 indexed citations

18.

Porter, Donald C., Gary W. Moy, & Victor D. Vacquier. (1988). CAMP-dependent protein kinase of sea urchin sperm phosphorylates sperm histone H1 on a single site.. Journal of Biological Chemistry. 263(6). 2750–2755. 22 indexed citations

19.

Nishioka, David, Donald C. Porter, James S. Trimmer, & Victor D. Vacquier. (1987). Dispersal of sperm surface antigens in the plasma membranes of polyspermically fertilized sea urchin eggs. Experimental Cell Research. 173(2). 628–632. 11 indexed citations

20.

Porter, Donald C. & Victor D. Vacquier. (1986). Phosphorylation of sperm histone H1 is induced by the egg jelly layer in the sea urchin Strongylocentrotus purpuratus. Developmental Biology. 116(1). 203–212. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact